Healthcare, Pharma, Medical Device etc.
Category
Japan, United states of America, Europe, Rest of World
Geographic Coverage
Not Available
Video URL
Not Available
Sale price (USD)
Not Available
Non-exclusive license price (USD)
Not Available
Exclusive license price (USD)
Not Available
Non-exclusive license royalty rate %
Availability
Patent family
Number of members in the patent family
Assignee(s) / Patent owner(s)
To see the additional information details please login and subscribe to a Premium account.

Cytostatic depsipeptides

Patent Granted The depsipeptide etamycin, a streptogramin-type of natural product from a marine actinomycete, was observed in 1990 to have an impact on aspects of mammalian gene expression, and a clinical trial was conducted in 1996 for its therapeutic potential against T-cell lymphoma.

BROKER APPLY submit an inquiry
photo To see the additional information details please login and subscribe to a Plus or Premium account.